Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MIRAMAR, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: GNTW), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced...
-
OXFORD, United Kingdom, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Sophos, a global leader in next-generation cybersecurity, today announced accelerated worldwide growth of MSP Connect, Sophos’...
-
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
-
ITASCA, Ill., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Revenera, producer of leading solutions that help technology companies build better products, accelerate time to value and monetize what matters,...
-
New York, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Virology Market: Key InsightsAccording to our latest study on “Virology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type,...
-
SEATTLE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global inflammatory bowel disease market is estimated to be valued at US$ 1,821.8 million in 2021 and is...
-
33 early and late-stage clinical programs across modalities and innovative discovery platformsUniquely positioned to lead in Alzheimer’s disease with ADUHELM® (aducanumab-avwa) and industry-leading...
-
PALO ALTO, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Today, HP Inc. introduced its newest devices, displays and accessories, designed for people who want technology that enables them to seamlessly...
-
NORCROSS, Ga., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that it has entered...
-
KNOXVILLE, TN, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...